Indeks Trombosit sebagai Indikator Komplikasi Mikrovaskular pada Penderita Diabetes Melitus Tipe 2
53
DAFTAR PUSTAKA
1. Shaw JE, Sicree RA, Zimmet PZ. Diabetes Atlas : Global
Estimates of the Prevalence of Diabetes for 2010 and 2030.
Diabetes Research and Clinical Practice .2010: 4-14
2. Zimmet P, Alberti KG, Shaw J. Global and Societal Implications
of the Diabetes Epidemic. Nature .2001: 414: 782-7
3. Yngen M. Platelet Function in Diabetes Mellitus. Karolinska
University Press, Stockholm, Sweden. 2005. 9-58
4. Yngen M. Platelet Hyperactivity in Diabetes Mellitus. European
Cardiology. 2005:1-6
5. Wild S, Roglic G, Green A, et al. Global Prevalence of Diabetes :
Estimates for the Year 2000 and Projections for 2030. Diabetes
Care. Volume 27(5). 2004: 1047-53
6. Ministry of Health, Republic of Indonesia. Centre of Data and
Information Indonesia Health Profile 2008. Jakarta; Ministry of
Health Republic of Indonesia 2010
7. Pranoto A. Prediabetes dan Diabetes Melitus. Divisi Endokrin
Metabolik. Bagian SMF Penyakit Dalam RSU Dr.Soetomo FK
Unair, Surabaya.Indonesia
8. Kusnadi Y. Gangguan Hemostasis dan Risiko Trombosis pada
Diabetes Melitus Tipe 2. Dalam: Sucipto KW, Zufry H (eds).
Universitas Sumatera Utara
54
Proceeding Book 4th Endocrinology & Diabetes Forum of
Sumatera Region Banda Aceh. USUPress . 2012: 123-5
9. Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan
dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. PB
PERKENI. Jakarta. 2011 : 1-56.
10. American Diabetes Association. Diagnosis and Classification of
Diabetes Mellitus. Diabetes Care. Volume 33. Supplement 1.
Januari 2010: S62-8
11. Fowler MJ. Microvascular and Macrovascular Complications of
Diabetes. Diabetes Foundation. Clinical Diabetes. Volume 26(2).
2008: 77-82
12. Salman R. Diabetic Microvascular Complications: Prevention
and Screening. Bahrain Medical Bulletin. Volume 26(2) .2004: 1-4
13. Takeuchi M, Takino J, Yamagishi S. Involvement of the Toxic
AGEs (TAGE)-RAGE system in the Pathogenesis of Diabetic
Vascular Complications; A Novel Therapeutic Strategy. Current
Drug Targets. Volume 11(11): 1468-82
14. Syafril S. Efek Pleiotropik Atorvastatin Terhadap Komplikasi
Vaskular Diabetes. Dalam: Sucipto KW, Zufry H (eds). Proceeding
Book 4th Endocrinology & Diabetes Forum of Sumatera Region
Banda Aceh. USUPress. 2012: 142-50
Universitas Sumatera Utara
55
15.Jindal S, Gupta S, Gupta R, et al. Platelet Indices in Diabetes
Mellitus: Indicator of Diabetic Microvascular Complications.
Hematology. Vol 16(2).2011: 86-9
16.Bancroft AJ, Abel EW, Mclaren M, et al. Mean Platelet Volume is
a Useful Parameter: a Reproducible Routine Method Using a
Modified Coulter Thrombocytometer. Platelets. 11(7). 2000: 37987
17.Bath PM,
Butterworth
Physiology
and
RJ.
Vascular
Platelet Size
Disease.
: Measurement,
Blood
Coagulation
&
Fibrinolysis. 7(2). 1996: 157-61
18.Hekimsoy Z, Payzin B, Ornek T, et al. Mean Platelet Volume in
Type
2
Diabetic
Patients.
Journal
of
Diabetes
and
its
Complications 18. 2004. 173-6
19.Papanas N, Symeonidis G, Maltezos E, et al. Mean Platelet
Volume in Patients with Type 2 Diabetes Mellitus. Platelets.
15(8). 2004: 475-8
20.Zuberi BF, Akhtar N, Afsar S. Comparison of Mean Platelet
Volume in Patients with Diabetes Mellitus, Impaired Fasting
Glucose and Non-Diabetic Subjects. Singapore Medical Journal.
49(2). 2008: 114-6
21.Demirtunc R, Duman D, Basar M, et al. The Relationship between
Glycemic Control and Platelet Activity in Type 2 Diabetes
Universitas Sumatera Utara
56
Mellitus. Journal of Diabetes and Its Cpmplications. 23. 2009: 8994
22. Purnamasari D. Diagnosis dan Klasifikasi Diabetes Melitus. Dalam:
Sudoyo AW dkk (eds). Buku Ajar Ilmu Penyakit Dalam. Jilid III.
Edisi ke-5. InternaPublishing. Jakarta. 2009: 1880-3
23. Sugondo S. Diagnosis dan Klasifikasi Diabetes Melitus Terkini.
Dalam: Penatalaksanaan Diabetes Melitus Terpadu. Balai
Penerbit FKUI. Jakarta. 2005: 17-27
24.Powers AC. Diabetes Mellitus. In: Fauci AS, Braunwald E, Hauser
SL, et al (eds). Harrison’s Principles of Internal Medicine. 17th
edition. San Fransisco. McGraw-hill Companies. 2008: 2275-302
25. Tjokroprawiro A, Inlacin®, The Novel Insulin Sensitizer for Patients
with T2DM (Its Roles on Mono-and Add-on Therapy): Dalam
Sucipto KW, Zufry H (eds). Proceeding Book, 4th Endocrinology
& Diabetes Forum of Sumatera Region. Banda Aceh. USU
Press. 2012: 62-7
26. Hadisaputro S, Setyawan H. Epidemiologi dan Faktor Risiko
Terjadinya Diabetes Melitus Tipe 2. Dalam: Darmono dkk (eds).
Naskah lengkap Diabetes Melitus Ditinjau dari Berbagai Aspek
Penyakit Dalam. Badan Penerbit Universitas Diponegoro. 2007:
133-51
Universitas Sumatera Utara
57
27. Sugondo S. Diabetes Melitus sebagai Faktor Resiko Utama
Penyakit
Yulherina
Kardiovaskular.
(ed).
Ikatan
Dokter
Indonesia.Jakarta. 2006: 1-45
28. Funk JL. Penyakit Pankreas Endokrin. Dalam: McPhee SJ, Ganong
WF. Patofisiologi Penyakit : Pengantar Menuju Kedokteran
Klinis. Edisi 5. EGC. 2011: 557-85
29. Situmorang TD. Perjalanan Klinik Penyakit Ginjal Diabetik. Dalam:
Naskah Lengkap The 5th Jakarta Nephrology & Hypertension
Course and Symposium on Hypertension. PERNEFRI. 2005:424
30. Henrika
F.
Pemeriksaan
Protein
Urin:
Protein,
Albumin/mikroalbumin, Protein Bence Jones, Hemoglobinuria dan
Mioblobinuria.
Dalam:
Oesman
F
(ed).
Pendidikan
Berkesinambungan Patologi Klinik 2010. Departemen Patologi
Klinik Fakultas Kedokteran Universitas Indonesia. Jakarta.
2010: 18-29
31. Hendromartono. Nefropati Diabetik. Dalam: Sudoyo AW dkk (eds) :
Buku
Ajar
Ilmu
Penyakit
Dalam.
Jilid
III.
Edisi
ke-5.
InternaPublishing. Jakarta. 2009: 1942-6
32. Pagana KD, Pagana TJ. Microalbumin (MA). In: Mosby’s Manual
of Diagnostic and Laboratory Tests. 3rd edition. Mosby Elsevier.
2006: 985-7
Universitas Sumatera Utara
58
33. Tobe SW, McFarlane PA, Naimark DM. Microalbuminuria in
Diabetes Mellitus. Canadian Medical Association.167(5). 2002:
499-503
34. Immanuel S. Mikroalbuminuria: Update: Petanda Disfungsi Endotel.
Dalam: Suryaatmadja M (ed). Pendidikan Berkesinambungan
Patologi Klinik 2006. Departemen Patologi Klinik Fakultas
Kedokteran Universitas Indonesia. Jakarta. Agustus 2006: 120-37
35. Anonymous. Cobas Integra 400/700/800. Albumin (Turbidimetric)
Urine and CSF Application. Roche.2005-03.V 6 EN:1-5
36. Fong DS, Aiello L, Gardner T, et al. Diabetic Retinopathy.
Diabetes Care.26 (suppl-1). 2003: s99-s102
37. Ozmen B, Guclu F, Kafesciler S, et al. The Relationship Between
Glycosylated
Haemoglobin
and
Diabetic
Retinopathy
in
Patients Type 2 Diabetes. Turk Jem .11. 2007: 10-5
38. Pandelaki K. Retinopati Diabetik. Dalam: Sudoyo AW dkk (eds) :
Buku
Ajar
Ilmu
Penyakit
Dalam.
Jilid
III.
Edisi
ke-5.
InternaPublishing. Jakarta. 2009: 1930-6
39. Subekti I. Neuropati Diabetik. Dalam: Sudoyo AW dkk (eds) : Buku
Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5. InternaPublishing.
Jakarta. 2009: 1947-51
40. Johns CS. Platelet Function Testing. Clinical Hemost Review. 18.
2004: 1-7
Universitas Sumatera Utara
59
41. Laffan M, Manning R. Investigation of Haemostasis. In : Lewis SM,
Bain BJ, Bates I (eds). Dacie and Lewis Practical Haematology.
10th edition. Philadelphia : Churchill Livingstone. 2003 : 379-440.
42. Suharti C. Dasar-Dasar Hemostasis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam.
Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta.
2006: 749-754.
43. Oesman F, Setiabudy RD. Fisiologi Hemostasis dan Fibrinolisis.
Dalam: Setiabudy RD. Hemostasis dan Trombosis. Edisi ke-3.
Balai Penerbit FKUI. Jakarta. 2007: 1-8.
44. Tambunan KL. Patogenesis Trombosis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam.
Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta;
2006 : 755-758.
45. Miller JL, Rao K. Blood Platelets and Von Willebrand Disease. In:
McPherson RA, Pincus MR (eds). Henry`s Clinical Diagnosis and
Management by Laboratory Methods, 21st edition. USA: Elsevier.
2007: 747-754
46. Ikeda Y, Matsubara Y, Kamata T. Platelet Immunology: Structure,
Functions and Polymorphisms of Membrane Glycoproteins. In:
Gresele P, Fuster V, Page JA, et al. (eds.). Platelets in
Hematologic and Cardiovascular Disorders. UK: Cambridge
University Press. 2008: 21-30
Universitas Sumatera Utara
60
47. Calverley DC, Maness LJ. Platelet Function in Hemostasis and
Thrombosis. In : Greer JP, Foerster J, Lukens JN, et al (eds).
Wintrobe`s Clinical Hematology. 11th edition. Lippincott Williams
and Wilkins. USA. 2004 : 651-669.
48. Brass LF, Stalker TJ. Mechanism of Platelet Activation. In : Gresele
P, Fuster V, Page JA. Et al (eds). Platelets in Hematologic and
Cardiovascular Disorders. Cambridge University Press. UK.
2008: 37-48.
49. Setiabudy
RD.
Pemantauan
Obat
Anti
Trombosit.
Dalam:
Pendidikan Berkesinambungan Patologi Klinik. Bagian Patologi
Klinik FK UI. Jakarta. 2004: 121-133.
50. Ferreiro JL, Gomez JA, Angiolillo DJ. Platelet Abnormalities in
Diabetes Mellitus. Diabetes & Vascular Disease Research. 7(4).
2010: 251-9
51. Vinik AI, Erbas T, Nolan R, et al. Platelet Dysfunction in Diabetes
Mellitus. Diabetes Care. Volume 24(8). Agustus 2001:1476-85
52. Schneider DJ. Factors Contributing to Increased Platelet
Reactivity in People with Diabetes. Diabetes Care. Volume 32(4).
April 2009: 525-7
53. Bain BJ, Bates I. Basic Haematological Techniques. In : Lewis SM,
Bain BJ, Bates I (eds). Dacie and Lewis Practical Haematology.
9th edition. Philadelphia. Churchill Livingstone. 2001: 19-42
Universitas Sumatera Utara
61
54. Anonymous. Sysmex XT-2000i/XT-1800i. Introduction for Use.
Quality Control
55. Pagana KD, Pagana TJ. Platelet Volume, Mean (Mean Platelet
Volume/MPV). In: Mosby’s Manual of Diagnostic and Laboratory
Tests. 3rd edition. Mosby Elsevier.2006:412-4
56. Kodiatte TA, Manikyam UK, Rao SB. Mean Platelet Volume in
Type 2 Diabetes Mellitus. Journal of Laboratory Physicians. Vol 4.
Jan-Jun 2012: 5-9
57. Halushka PV,Lurie D & Colwell JA. Increased Synthesis of
Prostaglandin-E-like Material by Platelets from Patients with
Diabetes
Mellitus.
New
England
Journal
of
Medicine.1977;297:1306-10
58. Wahyuni AS. Statistika Kedokteran (Disertai aplikasi dengan
SPSS)
59. American Academy of Ophthalmology Retina Panel. Preferred
Practice
Pattern
Guidelines.
Diabetic
Retinopathy.
San
Francisco, CA. American Academy of Ophthalmology.2008 (4th
Printing 2012). Available at : www.aao.org/ppp. (Access on
November,2012)
60. Anonymous. Cobas Integra 400/700/800. Creatinine plus ver.2
Roche.2005-05.V 3 EN:1-4
61. Anonymous. e-Check Assay Sheet for XT 2000i. Lot. No.
****0810, ****0811, ****0812.
Universitas Sumatera Utara
62
62. Anonymous. Albumin Urine/CSF Package Insert Calibrator.
Cobas. Roche/Hitachi analyzers. p 1-4
63. Anonymous. Precinorm PUC Package Insert Control. Cobas.
Roche/Hitachi analyzers. p 1
64. Anonymous. Creatinine Package Insert Calibrator. Cobas.
Integra 400/800 analyzers. p 14
65. Anonymous. Precinorm U Package Insert Control. Cobas.
Integra 400/800 analyzers. p 17
66. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean
Platelet Volume in Patients with Metabolic Syndrome and its
Relationship with Coronary Artery Disease. Thromb Res
2007;120:245–50.
67. Martyn CN, Matthews DM, Popp-Snijders, Tucker J, et al. Effects
of Sorbinil Treatment on Erythrocytes and Platelets of Persons
with Diabetes. Diabetes Care, Vol. 9. 1. Januari-Februari. 1986:369
68. Karpen CW, Pritchard KA, Merola AJ, et al. Alterations of the
Prostacyclin-Thromboxane Ratio in Streptozotocin Induced
Diabetic Rats. Prostaglandins Leukotrienes Med. 1982; 8:93-103.
69. Aydınlı S, Saydam G, Şahin F, et al. The Relationship between
Mean Platelet Volume, In-vitro Platelet Function Tests and
Microvascular Complications in Type 2 Diabetes Mellitus. Turk
Hematoloji Onkoloji Dergisi. 14.2004:193−199.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. Shaw JE, Sicree RA, Zimmet PZ. Diabetes Atlas : Global
Estimates of the Prevalence of Diabetes for 2010 and 2030.
Diabetes Research and Clinical Practice .2010: 4-14
2. Zimmet P, Alberti KG, Shaw J. Global and Societal Implications
of the Diabetes Epidemic. Nature .2001: 414: 782-7
3. Yngen M. Platelet Function in Diabetes Mellitus. Karolinska
University Press, Stockholm, Sweden. 2005. 9-58
4. Yngen M. Platelet Hyperactivity in Diabetes Mellitus. European
Cardiology. 2005:1-6
5. Wild S, Roglic G, Green A, et al. Global Prevalence of Diabetes :
Estimates for the Year 2000 and Projections for 2030. Diabetes
Care. Volume 27(5). 2004: 1047-53
6. Ministry of Health, Republic of Indonesia. Centre of Data and
Information Indonesia Health Profile 2008. Jakarta; Ministry of
Health Republic of Indonesia 2010
7. Pranoto A. Prediabetes dan Diabetes Melitus. Divisi Endokrin
Metabolik. Bagian SMF Penyakit Dalam RSU Dr.Soetomo FK
Unair, Surabaya.Indonesia
8. Kusnadi Y. Gangguan Hemostasis dan Risiko Trombosis pada
Diabetes Melitus Tipe 2. Dalam: Sucipto KW, Zufry H (eds).
Universitas Sumatera Utara
54
Proceeding Book 4th Endocrinology & Diabetes Forum of
Sumatera Region Banda Aceh. USUPress . 2012: 123-5
9. Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan
dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. PB
PERKENI. Jakarta. 2011 : 1-56.
10. American Diabetes Association. Diagnosis and Classification of
Diabetes Mellitus. Diabetes Care. Volume 33. Supplement 1.
Januari 2010: S62-8
11. Fowler MJ. Microvascular and Macrovascular Complications of
Diabetes. Diabetes Foundation. Clinical Diabetes. Volume 26(2).
2008: 77-82
12. Salman R. Diabetic Microvascular Complications: Prevention
and Screening. Bahrain Medical Bulletin. Volume 26(2) .2004: 1-4
13. Takeuchi M, Takino J, Yamagishi S. Involvement of the Toxic
AGEs (TAGE)-RAGE system in the Pathogenesis of Diabetic
Vascular Complications; A Novel Therapeutic Strategy. Current
Drug Targets. Volume 11(11): 1468-82
14. Syafril S. Efek Pleiotropik Atorvastatin Terhadap Komplikasi
Vaskular Diabetes. Dalam: Sucipto KW, Zufry H (eds). Proceeding
Book 4th Endocrinology & Diabetes Forum of Sumatera Region
Banda Aceh. USUPress. 2012: 142-50
Universitas Sumatera Utara
55
15.Jindal S, Gupta S, Gupta R, et al. Platelet Indices in Diabetes
Mellitus: Indicator of Diabetic Microvascular Complications.
Hematology. Vol 16(2).2011: 86-9
16.Bancroft AJ, Abel EW, Mclaren M, et al. Mean Platelet Volume is
a Useful Parameter: a Reproducible Routine Method Using a
Modified Coulter Thrombocytometer. Platelets. 11(7). 2000: 37987
17.Bath PM,
Butterworth
Physiology
and
RJ.
Vascular
Platelet Size
Disease.
: Measurement,
Blood
Coagulation
&
Fibrinolysis. 7(2). 1996: 157-61
18.Hekimsoy Z, Payzin B, Ornek T, et al. Mean Platelet Volume in
Type
2
Diabetic
Patients.
Journal
of
Diabetes
and
its
Complications 18. 2004. 173-6
19.Papanas N, Symeonidis G, Maltezos E, et al. Mean Platelet
Volume in Patients with Type 2 Diabetes Mellitus. Platelets.
15(8). 2004: 475-8
20.Zuberi BF, Akhtar N, Afsar S. Comparison of Mean Platelet
Volume in Patients with Diabetes Mellitus, Impaired Fasting
Glucose and Non-Diabetic Subjects. Singapore Medical Journal.
49(2). 2008: 114-6
21.Demirtunc R, Duman D, Basar M, et al. The Relationship between
Glycemic Control and Platelet Activity in Type 2 Diabetes
Universitas Sumatera Utara
56
Mellitus. Journal of Diabetes and Its Cpmplications. 23. 2009: 8994
22. Purnamasari D. Diagnosis dan Klasifikasi Diabetes Melitus. Dalam:
Sudoyo AW dkk (eds). Buku Ajar Ilmu Penyakit Dalam. Jilid III.
Edisi ke-5. InternaPublishing. Jakarta. 2009: 1880-3
23. Sugondo S. Diagnosis dan Klasifikasi Diabetes Melitus Terkini.
Dalam: Penatalaksanaan Diabetes Melitus Terpadu. Balai
Penerbit FKUI. Jakarta. 2005: 17-27
24.Powers AC. Diabetes Mellitus. In: Fauci AS, Braunwald E, Hauser
SL, et al (eds). Harrison’s Principles of Internal Medicine. 17th
edition. San Fransisco. McGraw-hill Companies. 2008: 2275-302
25. Tjokroprawiro A, Inlacin®, The Novel Insulin Sensitizer for Patients
with T2DM (Its Roles on Mono-and Add-on Therapy): Dalam
Sucipto KW, Zufry H (eds). Proceeding Book, 4th Endocrinology
& Diabetes Forum of Sumatera Region. Banda Aceh. USU
Press. 2012: 62-7
26. Hadisaputro S, Setyawan H. Epidemiologi dan Faktor Risiko
Terjadinya Diabetes Melitus Tipe 2. Dalam: Darmono dkk (eds).
Naskah lengkap Diabetes Melitus Ditinjau dari Berbagai Aspek
Penyakit Dalam. Badan Penerbit Universitas Diponegoro. 2007:
133-51
Universitas Sumatera Utara
57
27. Sugondo S. Diabetes Melitus sebagai Faktor Resiko Utama
Penyakit
Yulherina
Kardiovaskular.
(ed).
Ikatan
Dokter
Indonesia.Jakarta. 2006: 1-45
28. Funk JL. Penyakit Pankreas Endokrin. Dalam: McPhee SJ, Ganong
WF. Patofisiologi Penyakit : Pengantar Menuju Kedokteran
Klinis. Edisi 5. EGC. 2011: 557-85
29. Situmorang TD. Perjalanan Klinik Penyakit Ginjal Diabetik. Dalam:
Naskah Lengkap The 5th Jakarta Nephrology & Hypertension
Course and Symposium on Hypertension. PERNEFRI. 2005:424
30. Henrika
F.
Pemeriksaan
Protein
Urin:
Protein,
Albumin/mikroalbumin, Protein Bence Jones, Hemoglobinuria dan
Mioblobinuria.
Dalam:
Oesman
F
(ed).
Pendidikan
Berkesinambungan Patologi Klinik 2010. Departemen Patologi
Klinik Fakultas Kedokteran Universitas Indonesia. Jakarta.
2010: 18-29
31. Hendromartono. Nefropati Diabetik. Dalam: Sudoyo AW dkk (eds) :
Buku
Ajar
Ilmu
Penyakit
Dalam.
Jilid
III.
Edisi
ke-5.
InternaPublishing. Jakarta. 2009: 1942-6
32. Pagana KD, Pagana TJ. Microalbumin (MA). In: Mosby’s Manual
of Diagnostic and Laboratory Tests. 3rd edition. Mosby Elsevier.
2006: 985-7
Universitas Sumatera Utara
58
33. Tobe SW, McFarlane PA, Naimark DM. Microalbuminuria in
Diabetes Mellitus. Canadian Medical Association.167(5). 2002:
499-503
34. Immanuel S. Mikroalbuminuria: Update: Petanda Disfungsi Endotel.
Dalam: Suryaatmadja M (ed). Pendidikan Berkesinambungan
Patologi Klinik 2006. Departemen Patologi Klinik Fakultas
Kedokteran Universitas Indonesia. Jakarta. Agustus 2006: 120-37
35. Anonymous. Cobas Integra 400/700/800. Albumin (Turbidimetric)
Urine and CSF Application. Roche.2005-03.V 6 EN:1-5
36. Fong DS, Aiello L, Gardner T, et al. Diabetic Retinopathy.
Diabetes Care.26 (suppl-1). 2003: s99-s102
37. Ozmen B, Guclu F, Kafesciler S, et al. The Relationship Between
Glycosylated
Haemoglobin
and
Diabetic
Retinopathy
in
Patients Type 2 Diabetes. Turk Jem .11. 2007: 10-5
38. Pandelaki K. Retinopati Diabetik. Dalam: Sudoyo AW dkk (eds) :
Buku
Ajar
Ilmu
Penyakit
Dalam.
Jilid
III.
Edisi
ke-5.
InternaPublishing. Jakarta. 2009: 1930-6
39. Subekti I. Neuropati Diabetik. Dalam: Sudoyo AW dkk (eds) : Buku
Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5. InternaPublishing.
Jakarta. 2009: 1947-51
40. Johns CS. Platelet Function Testing. Clinical Hemost Review. 18.
2004: 1-7
Universitas Sumatera Utara
59
41. Laffan M, Manning R. Investigation of Haemostasis. In : Lewis SM,
Bain BJ, Bates I (eds). Dacie and Lewis Practical Haematology.
10th edition. Philadelphia : Churchill Livingstone. 2003 : 379-440.
42. Suharti C. Dasar-Dasar Hemostasis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam.
Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta.
2006: 749-754.
43. Oesman F, Setiabudy RD. Fisiologi Hemostasis dan Fibrinolisis.
Dalam: Setiabudy RD. Hemostasis dan Trombosis. Edisi ke-3.
Balai Penerbit FKUI. Jakarta. 2007: 1-8.
44. Tambunan KL. Patogenesis Trombosis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam.
Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta;
2006 : 755-758.
45. Miller JL, Rao K. Blood Platelets and Von Willebrand Disease. In:
McPherson RA, Pincus MR (eds). Henry`s Clinical Diagnosis and
Management by Laboratory Methods, 21st edition. USA: Elsevier.
2007: 747-754
46. Ikeda Y, Matsubara Y, Kamata T. Platelet Immunology: Structure,
Functions and Polymorphisms of Membrane Glycoproteins. In:
Gresele P, Fuster V, Page JA, et al. (eds.). Platelets in
Hematologic and Cardiovascular Disorders. UK: Cambridge
University Press. 2008: 21-30
Universitas Sumatera Utara
60
47. Calverley DC, Maness LJ. Platelet Function in Hemostasis and
Thrombosis. In : Greer JP, Foerster J, Lukens JN, et al (eds).
Wintrobe`s Clinical Hematology. 11th edition. Lippincott Williams
and Wilkins. USA. 2004 : 651-669.
48. Brass LF, Stalker TJ. Mechanism of Platelet Activation. In : Gresele
P, Fuster V, Page JA. Et al (eds). Platelets in Hematologic and
Cardiovascular Disorders. Cambridge University Press. UK.
2008: 37-48.
49. Setiabudy
RD.
Pemantauan
Obat
Anti
Trombosit.
Dalam:
Pendidikan Berkesinambungan Patologi Klinik. Bagian Patologi
Klinik FK UI. Jakarta. 2004: 121-133.
50. Ferreiro JL, Gomez JA, Angiolillo DJ. Platelet Abnormalities in
Diabetes Mellitus. Diabetes & Vascular Disease Research. 7(4).
2010: 251-9
51. Vinik AI, Erbas T, Nolan R, et al. Platelet Dysfunction in Diabetes
Mellitus. Diabetes Care. Volume 24(8). Agustus 2001:1476-85
52. Schneider DJ. Factors Contributing to Increased Platelet
Reactivity in People with Diabetes. Diabetes Care. Volume 32(4).
April 2009: 525-7
53. Bain BJ, Bates I. Basic Haematological Techniques. In : Lewis SM,
Bain BJ, Bates I (eds). Dacie and Lewis Practical Haematology.
9th edition. Philadelphia. Churchill Livingstone. 2001: 19-42
Universitas Sumatera Utara
61
54. Anonymous. Sysmex XT-2000i/XT-1800i. Introduction for Use.
Quality Control
55. Pagana KD, Pagana TJ. Platelet Volume, Mean (Mean Platelet
Volume/MPV). In: Mosby’s Manual of Diagnostic and Laboratory
Tests. 3rd edition. Mosby Elsevier.2006:412-4
56. Kodiatte TA, Manikyam UK, Rao SB. Mean Platelet Volume in
Type 2 Diabetes Mellitus. Journal of Laboratory Physicians. Vol 4.
Jan-Jun 2012: 5-9
57. Halushka PV,Lurie D & Colwell JA. Increased Synthesis of
Prostaglandin-E-like Material by Platelets from Patients with
Diabetes
Mellitus.
New
England
Journal
of
Medicine.1977;297:1306-10
58. Wahyuni AS. Statistika Kedokteran (Disertai aplikasi dengan
SPSS)
59. American Academy of Ophthalmology Retina Panel. Preferred
Practice
Pattern
Guidelines.
Diabetic
Retinopathy.
San
Francisco, CA. American Academy of Ophthalmology.2008 (4th
Printing 2012). Available at : www.aao.org/ppp. (Access on
November,2012)
60. Anonymous. Cobas Integra 400/700/800. Creatinine plus ver.2
Roche.2005-05.V 3 EN:1-4
61. Anonymous. e-Check Assay Sheet for XT 2000i. Lot. No.
****0810, ****0811, ****0812.
Universitas Sumatera Utara
62
62. Anonymous. Albumin Urine/CSF Package Insert Calibrator.
Cobas. Roche/Hitachi analyzers. p 1-4
63. Anonymous. Precinorm PUC Package Insert Control. Cobas.
Roche/Hitachi analyzers. p 1
64. Anonymous. Creatinine Package Insert Calibrator. Cobas.
Integra 400/800 analyzers. p 14
65. Anonymous. Precinorm U Package Insert Control. Cobas.
Integra 400/800 analyzers. p 17
66. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean
Platelet Volume in Patients with Metabolic Syndrome and its
Relationship with Coronary Artery Disease. Thromb Res
2007;120:245–50.
67. Martyn CN, Matthews DM, Popp-Snijders, Tucker J, et al. Effects
of Sorbinil Treatment on Erythrocytes and Platelets of Persons
with Diabetes. Diabetes Care, Vol. 9. 1. Januari-Februari. 1986:369
68. Karpen CW, Pritchard KA, Merola AJ, et al. Alterations of the
Prostacyclin-Thromboxane Ratio in Streptozotocin Induced
Diabetic Rats. Prostaglandins Leukotrienes Med. 1982; 8:93-103.
69. Aydınlı S, Saydam G, Şahin F, et al. The Relationship between
Mean Platelet Volume, In-vitro Platelet Function Tests and
Microvascular Complications in Type 2 Diabetes Mellitus. Turk
Hematoloji Onkoloji Dergisi. 14.2004:193−199.
Universitas Sumatera Utara